Torrent Pharmaceuticals Ltd News

Pharma stocks zoom: Laurus Labs, Aurobindo hit new highs in trade

The BSE Healthcare index rallied over 1% in Monday's trade. Thus far in the financial year 2026-27, it outperformed the market by soaring 25%, against a near 4% rise in the BSE Sensex.

Top 10 pharma firms sustain volume growth as smaller rivals struggle

The top 10 in August included Sun Pharma, Cipla, Abbott, Mankind Pharma, Torrent Pharmaceuticals, Alkem Laboratories, Intas Pharmaceuticals, Lupin, Zydus Lifesciences and Dr Reddy's Laboratories

Torrent Pharmaceuticals Q1 result: Net profit up at 3.3% at ₹566 crore

Torrent Pharmaceuticals on Tuesday reported a 3.3 per cent increase in consolidated net profit at Rs 566 crore in the first quarter ended June 30, 2026. The company had posted a consolidated net profit of Rs 548 crore in the corresponding quarter last fiscal, Torrent Pharmaceuticals Ltd said in a regulatory filing. Consolidated total revenue from operations in the first quarter stood at Rs 4,921 crore as against Rs 3,178 crore in the year-ago period, it added. Total expenses in the quarter under review were higher at Rs 4,155 crore as compared to Rs 2,403 crore in the same quarter a year ago, the company said. India revenues were at Rs 2,157 crore in the first quarter, up 19 per cent from the year-ago period, and US revenues were also at Rs 418 crore, up 36 per cent, it added. Brazil revenues stood at Rs 277 crore, up 27 per cent, and the same for Germany was at Rs 318 crore, up 3 per cent year-on-year, the company said.

Healthcare up for 4th straight month; Divis, Laurus, Torrent at new highs

The BSE Healthcare hit a new high of 51,108 on Friday, rallying 3.7% in July. The index has surged 22% since April 2026.

Pharma index surges 2%; Torrent, Mankind, Cipla, Aurobindo soar up to 5%

Pharma stocks: RPG Life, Thyrocare, Hester Biosciences, Rubicon Research, IOL Chemicals, Emcure and Suven Life from the BSE Healthcare index rallied between 4% and 8% on Monday.

Stocks to Watch today: TCS, Maruti, JSW Steel, JK Tyre, Federal Bank & more

Stocks to watch today: TCS, Maruti Suzuki, JSW Steel, JK Tyre, Federal Bank, AU SFB, SAIL, Nalco, NLC India, Anand Rathi Wealth, JSW Steel, Cummins India, among others, will be in focus today

Pharma stocks: Lupin, Torrent hit new peaks; Sun nears summit; here's why

Pharma stock rally: Orchid Pharma, Hikal, Unichem Labs, IOL Chemicals, SPARC, RPG Life Sciences and Acutaas Chemicals surged up to 13% in Wednesday's trade.

Stocks to Watch today: Maruti, RCF, BHEL, Torrent Pharma, Tata Power, IHCL

Stocks to watch today: Maruti Suzuki, Uno Minda, BHEL, Torrent Pharma, Tata Power, IHCL, IDFC First Bank, Kalyan Jewellers, Premier Energies, RCF, RRP Defense, among others, will be in focus today

Stocks to Watch today: Trent, Titan, Power Grid, Cochin Shipyard, TVS Motor

Stocks to watch today: Power Grid, Sterlite Technologies, ZEN Technologies, TVS Motor Company, Varun Beverages, Torrent Pharma, Cochin Shipyard, Titan, Trent, among others, will be in focus today

Nifty Pharma rallies 2%; Laurus, Ipca, Aurobindo, Torrent hit record highs

In the past month, the Nifty Pharma index outperformed the market by surging 7.4 per cent, as compared to 4.2 per cent rise in the Nifty 50.

India's pharma market gets a lift from rising volumes, not just prices

Chronic therapies and GLP-1 adoption help broaden growth drivers as the market expands over 10 per cent in April and May

India business, margins remain key growth drivers for Torrent Pharma

The stock delivered higher returns than the benchmark Nifty Pharma over the past year

F&O Cues: Analyst shares Bull Spread strategy on Bank Nifty, Torrent Pharma

Nandish Shah of HDFC Securities has shared a Bear Spread strategy on Bank Nifty, and Torrent Pharma

Torrent Pharma rises 5% on Q4 beat; brokerages divided on JBCP integration

Torrent Pharma's revenue from operations rose 42 per cent Y-o-Y to ₹4,197 crore in Q4FY26 from ₹2,959 crore in Q4FY25

Torrent Pharma Q4 profit falls 27% to ₹364 cr due to exceptional item outgo

Torrent Pharmaceuticals Ltd on Friday reported a 27 per cent decline in profit after tax to Rs 364 crore in the fourth quarter ended March 31, 2026, impacted by exceptional items outgo. The company had posted a net profit of Rs 498 crore in the corresponding period of the preceding fiscal, Torrent Pharmaceuticals said in a statement. Total revenue from operations in the fourth quarter of FY26 stood at Rs 4,197 crore as against Rs 2,959 crore in the year-ago period, it added. The company had exceptional items outgo of Rs 66 crore in the quarter, as per the regulatory filing. The board has recommended a final dividend of Rs 9 per equity share of a face value of Rs 5 each. The pharma company's India business revenue stood at Rs 2,215 crore, up 43 per cent, in the quarter, while the Brazil revenue came in at Rs 455 crore, up by 30 per cent. Revenue from the US business stood at Rs 396 crore, up 31 per cent year-on-year, Torrent Pharma said. For FY26, net profit increased to Rs 2,138

Torrent Pharma Q4 profit falls 21.9% on high expenses despite revenue boost

Torrent Pharma's Q4 profit dropped 22% as JB Pharma integration costs pushed up expenses, despite strong growth in semaglutide-led revenues

Why pharma stocks are emerging as safe bet amid global market turmoil

The pharma sector is seen as a safe bet because demand remains steady even during inflation or economic slowdowns. Besides, companies earn revenue from multiple global markets, which helps reduce risk

Patent wins vs tariff risks: Analysts pick top pharma stocks to bet on

Pharma stocks have, so far, outperformed the markets in 2026. However, as risk around Trump tariffs resurface, analysts suggest shifting to domestic-focused companies. Here's the investment strategy.